Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,500 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 5 August 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at so that we can update the bibliography.


 (PDF, 3MB, 207 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website



Export 12 results:
Author Title [ Type(Desc)] Year
Filters: First Letter Of Title is P and Author is van Staa, T. P.  [Clear All Filters]
Journal Article
B. Zhang, de Vries, F., Setakis, E., and van Staa, T. P., The pattern of risk of myocardial infarction in patients taking asthma medication: a study with the General Practice Research Database, J Hypertens, vol. 27, pp. 1485-92, 2009.
H. J. I. De Jong, Tervaert, J. W. Cohen, Lalmohamed, A., de Vries, F., Vandebriel, R. J., Van Loveren, H., Klungel, O. H., and van Staa, T. P., Pattern of risks of rheumatoid arthritis among patients using statins: A cohort study with the clinical practice research datalink, PLoS One, vol. 13, p. e0193297, 2018.
H. J. I. De Jong, van Staa, T. P., Lalmohamed, A., de Vries, F., Vandebriel, R. J., Van Loveren, H., Klungel, O. H., and Tervaert, J. W. Cohen, Pattern of risks of systemic lupus erythematosus among statin users: a population-based cohort study, Ann Rheum Dis, vol. 76, pp. 1723-1730, 2017.
H. A. van den Ham, Klungel, O. H., Leufkens, H. G., and van Staa, T. P., The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation, J Thromb Haemost, vol. 11, pp. 107-15, 2013.
A. Lalmohamed, Macgregor, A. J., de Vries, F., Leufkens, H. G., and van Staa, T. P., Patterns of risk of cancer in patients with metal-on-metal hip replacements versus other bearing surface types: a record linkage study between a prospective joint registry and general practice electronic health records in England, PLoS One, vol. 8, p. e65891, 2013.
A. Dregan, van Staa, T. P., McDermott, L., McCann, G., Ashworth, M., Charlton, J., Wolfe, C. D., Rudd, A., Yardley, L., Gulliford, M. C., and Steering, C. Trial, Point-of-care cluster randomized trial in stroke secondary prevention using electronic health records, Stroke, vol. 45, pp. 2066-71, 2014.
A. M. Gallagher, van Staa, T. P., Murray-Thomas, T., Schoof, N., Clemens, A., Ackermann, D., and Bartels, D. B., Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes, BMJ Open, vol. 4, p. e003839, 2014.
T. P. van Staa, Leufkens, H., Abenhaim, L., and Cooper, C., Postmarketing surveillance of the safety of cyclic etidronate, Pharmacotherapy, vol. 18, pp. 1121-8, 1998.
S. Rietbrock, Olson, M., and van Staa, T. P., The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates, Qjm, vol. 102, pp. 35-42, 2009.
T. P. van Staa, Gulliford, M., Ng, E. S., Goldacre, B., and Smeeth, L., Prediction of cardiovascular risk using Framingham, ASSIGN and QRISK2: how well do they predict individual rather than population risk?, PLoS One, vol. 9, p. e106455, 2014.
T. P. van Staa, Carr, D. F., O'Meara, H., McCann, G., and Pirmohamed, M., Predictors and outcomes of increases in creatine phosphokinase concentrations or rhabdomyolysis risk during statin treatment, Br J Clin Pharmacol, vol. 78, pp. 649-59, 2014.
T. P. van Staa, Abenhaim, L., Cooper, C., Zhang, B., and Leufkens, H. G., Public health impact of adverse bone effects of oral corticosteroids, Br J Clin Pharmacol, vol. 51, pp. 601-7, 2001.
[Page last reviewed 5 August 2020]